Joaquin Duato

Duato began his career in Johnson & Johnson in 1989 when he joined Janssen Pharmaceutica in Spain. After moving to the USA in 2002, Duato was appointed Executive Vice President, Worldwide Chairman, Pharmaceuticals in 2011. His growth strategy led to the turnaround of Johnson & Johnson’s struggling pharmaceutical business in the early 2000s. In 2018 when he was promoted to Vice-Chairman of Johnson & Johnson’s executive committee, he led the pharmaceuticals and consumer product divisions and oversaw supply-chain and technology operations. He also served as interim Chief Information Officer. Duato was appointed CEO in August 2021 which became effective on January 3, 2022. He was also appointed to the company’s board of directors.

Joaquin Duato is a board member of the U.S. Spain Council and previously served on boards with UNICEF USA, Tsinghua University School of Pharmaceutical Sciences, and the Hess Corporation. Duato was past chair of Pharmaceutical Research and Manufacturers of America (PhRMA). Duato was Healthcare Businesswomen’s Association Honorable Mentor honoree and EVP in 2017. In 2021, Duato was ranked #3 on the NJBIZ Manufacturing Power 50 list.

Joaquin Duato (born April 1962) is a Spanish-American business executive. Duato is a dual citizen of Spain and the United States. He is the chief executive officer (CEO) of Johnson & Johnson, an American multinational conglomerate. He is the eighth person to serve as CEO of Johnson & Johnson since it became a publicly-traded company in 1944.